nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, Her2-metastatic breast cancer

Simple item page
dc.contributor.authorHuober, J.
dc.contributor.authorHamilton, E.
dc.contributor.authorCortes, J.
dc.contributor.authorOzyilkan, O.
dc.contributor.authorChen, S.C.
dc.contributor.authorPetrakova, K.
dc.contributor.authorManikhas, A.
dc.contributor.authorJerusalem, G.
dc.contributor.authorHegg, R.
dc.contributor.authorChapman, S.
dc.contributor.authorYang, Z.
dc.contributor.authorChen, Y.
dc.contributor.authorJohnston, E.
dc.contributor.authorMartin, M.
dc.date.accessioned2022-06-14T11:52:58Z
dc.date.available2022-06-14T11:52:58Z
dc.date.issued2021
dc.identifier.endpage245en_US
dc.identifier.issn2296-5270en_US
dc.identifier.startpage244en_US
dc.identifier.urihttp://hdl.handle.net/11727/7020
dc.identifier.volume44en_US
dc.identifier.wos000760622600451en_US
dc.language.isoengen_US
dc.relation.journalONCOLOGY RESEARCH AND TREATMENTen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlenextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, Her2-metastatic breast canceren_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar